Product Pathways
BCP0353 LY335979
LY335979 is a selective Pgp (P-glycoprotein) inhibitor with a Ki of 59 nM, and does not modulate MRP-mediated resistance by MRP1 (ABCC1) and MRP2 (ABCC2).
BCP000716 PSC833(Valspodar)
P-glycoprotein (P-gp) modulator; inhibits P-gp-mediated multidrug-resistance (MDR).
BCP001081 LY335979(Zosuquidar)
A substance being studied in the treatment of cancer. LY335979 may help kill cancer cells resistant to anticancer drugs. Also called triclorhidrato of zosuquidar.
BCP001311 Diosmin
BCP001662 Tariquidar
Tariquidar is a P-glycoprotein inhibitor undergoing research as an adjuvant against multidrug resistance in cancer.
第一页 1 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.